AGEN vs HOLX · P/E 1.6, rev $68.3M vs P/E 32, rev $4.10B
Agenus Inc (AGEN) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the AGEN and HOLX stock pages for the full models.
Not investment advice.